KaloBios Emerges from Chapter 11 Bankruptcy
01 juil. 2016 07h00 HE
|
KaloBios Pharmaceuticals Inc.
Emerges as a transformed and revitalized company from a complicated bankruptcyReceives $14 million in equity financing to help recapitalize its businessAcquires rights to benznidazole for the...
KaloBios CEO to Present at the International Society for Neglected Tropical Diseases Conference
25 mai 2016 03h00 HE
|
Humanigen, Inc
BRISBANE, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIOQ), a development stage biopharmaceutical company focused on advancing treatments for neglected diseases,...
KaloBios Announces New Product Pricing Model
11 avr. 2016 08h00 HE
|
Humanigen, Inc
Model applies to all product candidatesFocus on affordability, transparency and reasonable returnCompany will not engage in aggressive pricing or “price-gouging” BRISBANE, Calif., April 11, 2016 ...